I-Mab
NASDAQ:IMAB

Watchlist Manager
I-Mab Logo
I-Mab
NASDAQ:IMAB
Watchlist
Price: 0.9397 USD -2.01% Market Closed
Market Cap: 76m USD
Have any thoughts about
I-Mab?
Write Note

I-Mab
Common Stock

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

I-Mab
Common Stock Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Common Stock CAGR 3Y CAGR 5Y CAGR 10Y
I-Mab
NASDAQ:IMAB
Common Stock
ÂĄ136k
CAGR 3-Years
11%
CAGR 5-Years
-86%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Common Stock
ÂĄ906k
CAGR 3-Years
4%
CAGR 5-Years
12%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Common Stock
ÂĄ1.3B
CAGR 3-Years
43%
CAGR 5-Years
27%
CAGR 10-Years
N/A
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Common Stock
ÂĄ6.6B
CAGR 3-Years
0%
CAGR 5-Years
6%
CAGR 10-Years
27%
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Common Stock
ÂĄ2.4B
CAGR 3-Years
14%
CAGR 5-Years
8%
CAGR 10-Years
12%
Imeik Technology Development Co Ltd
SZSE:300896
Common Stock
ÂĄ216.4m
CAGR 3-Years
22%
CAGR 5-Years
19%
CAGR 10-Years
N/A
No Stocks Found

I-Mab
Glance View

Market Cap
76m USD
Industry
Biotechnology

I-Mab operates as a clinical stage biopharmaceutical company. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2020-01-17.

IMAB Intrinsic Value
0.7454 USD
Overvaluation 21%
Intrinsic Value
Price

See Also

What is I-Mab's Common Stock?
Common Stock
136k CNY

Based on the financial report for Dec 31, 2023, I-Mab's Common Stock amounts to 136k CNY.

What is I-Mab's Common Stock growth rate?
Common Stock CAGR 5Y
-86%

Over the last year, the Common Stock growth was 36%. The average annual Common Stock growth rates for I-Mab have been 11% over the past three years , -86% over the past five years .

Back to Top